White Papers

Allograft Tissue Sterilization Using Irradiation–What are the Implications for Clinical Performance?
Musculoskeletal allograft tissue is typically procured and processed aseptically to avoid contamination with microorganisms. Nonetheless, aseptic handling of tissue does not eliminate the risk of tissue contamination or the potential for disease transmission nor does it render the tissue sterile.

Click here to access the LifeNet white paper.

Ensuring the Safety of Allograft Tissue
The risk of bacterial infection and disease transmission through tissue transplantation continues to cause significant concern among transplant recipients and implanting surgeons.

Click here to access the LifeNet white paper.

Creating a No-Lift, No-Transfer Environment in the OR
For the past two years, OR staff members at the Bascom Palmer Eye Institute in Miami, Florida, have been using a new patient transport chair to successfully address three high-profile operational and safety issues:

• patient fall hazards,
• risk of injury to staff members, and
• efficient overall patient flow.

Click here to access the TransMotion white paper.

Variations in Allograft Sterility Levels: Clinical and Economic Implications
Differences and discrepancies exist between sterility requirements for medical devices and biotechnology supply organizations. But what many don’t realize is that the same sterility standards are not applied to organizations supplying bone and tissue allografts.

Click here to access the LifeNet white paper.